Preimplantation Genetic Testing for Aneuploidies (PGT-A) will screen the chromosomal normality of each and every embryo culturing in vitro during your upcoming IVF treatment. PGT-A identifies high quality embryos by ruling out those with aneuploidy – an extra or missing chromosome.
Recent research statistics show that a PGT-A biopsy and screening dramatically increases a woman’s chance of conceiving a healthy baby through IVF – by up to 30 percent. Cells are extracted from a blastocyst embryo and evaluated by our expert embryologists. When aneuploidy embryos are detected, they are not transferred. Only high quality embryos are selected for fresh transfer or Frozen Embryo Transfer (FET) procedures.
Poor quality embryos result in:
PGT-A is conducted in conjunction with Cutting-Edge IVF Protocols.
Dr. John Zhang’s PGT-A technology expertise in conjunction with IVF offers the highest pregnancy success rates and best overall patient satisfaction. To schedule your initial consultation with Dr. John Zhang call 212.969.7422.